All Stories

  1. Cobalamin Metabolism Is a Key Process of Breast Cancer Cells That Offers New Ways for Diagnosis and Treatment
  2. Design and Semisynthesis of Aminocannabinoids as Neurological Magic Shotguns
  3. Dillapiole Dampens the Expression of the Major Virulence Genes of Francisella tularensis
  4. Cardio-pulmonary arrest in a patient revived with naloxone following reported use of 7-hydroxymitragynine
  5. From Kratom to Semi‐Synthetic Opioids: The Rise and Risks of MGM‐15
  6. Uncaria attenuata and its main corynanthean alkaloid, villocarine A, exert antinociceptive effects in rats via activation of central μ-opioid receptors
  7. Effects of kratom alkaloids on mesolimbic dopamine release
  8. Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets
  9. The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic α2 receptor activity in vitro and in vivo
  10. Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones
  11. Therapeutics to Treat Psychiatric and Neurological Disorders: A Promising Perspective from Algerian Traditional Medicine
  12. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
  13. The Polypharmacological Effects of Cannabidiol
  14. Natural Corynanthe-Type Cholinesterase Inhibitors from Malaysian Uncaria attenuata Korth.: Isolation, Characterization, In Vitro and In Silico Studies
  15. Directed Biosynthesis of Mitragynine Stereoisomers
  16. Chemical-proteomics Identify Peroxiredoxin-1 as an Actionable Target in Triple-negative Breast Cancer
  17. Interactive Effects of µ-Opioid and Adrenergic-α2 Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine
  18. Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects
  19. Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
  20. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance
  21. The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study
  22. Plant growth and phytoactive alkaloid synthesis in Mitragyna speciosa (kratom) in response to varying radiance
  23. Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors
  24. Activity of Mitragyna speciosa (“Kratom”) Alkaloids at Serotonin Receptors
  25. Correction to “Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery”
  26. Structure–Activity Relationships of the Antimalarial Agent Artemisinin 10. Synthesis and Antimalarial Activity of Enantiomers of rac-5β-Hydroxy-d-Secoartemisinin and Analogs: Implications Regarding the Mechanism of Action
  27. Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery
  28. Assessment of Contribution of 7‐Hydroxymitragynine and Mitragynine Pseudoindoxyl to the MU‐Opioid Activity of Mitragynine
  29. Mitragynine Attenuates the Development of Tolerance to and Withdrawal from Morphine in Rats
  30. Pharmacological Characterization of Mitragynine: Antinociception, Respiratory Depression, Self‐Administration, Drug Discrimination, Tolerance, and withdrawal in Rats
  31. Serotonin 5‐HT 1A Receptor Activity of Kratom Alkaloids Mitragynine, Paynantheine, and Speciogynine
  32. The Lofexidine‐Like Discriminative Effects of the Primary Kratom Alkaloid Mitragynine in Rats
  33. Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine
  34. Coumarins and other constituents from Deverra battandieri
  35. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Rats
  36. Exploring the Chemistry of Alkaloids from Malaysian Mitragyna speciosa (Kratom) and the Role of Oxindoles on Human Opioid Receptors
  37. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
  38. Proposed Mechanism for the Antitrypanosomal Activity of Quercetin and Myricetin Isolated from Hypericum afrum Lam.: Phytochemistry, In Vitro Testing and Modeling Studies
  39. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method
  40. Kratom (Mitragyna speciosa Korth.): A description on the ethnobotany, alkaloid chemistry, and neuropharmacology
  41. Chlorinated Guaiane-Type Sesquiterpene Lactones as Cytotoxic Agents against Human Tumor Cells
  42. Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
  43. Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
  44. Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
  45. Evaluation of the rewarding effects of mitragynine and 7‐hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats
  46. Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy
  47. Pharmacokinetics and Safety of Mitragynine in Beagle Dogs
  48. Characterization of Chemical Compounds and Antioxidant Activity of Centaurea solstitialis sp. schouwii (DC.) Q. et S. (Asteraceae)
  49. 3-O-Formyl -27-Hydroxyfusidic Acid: A New Metabolite of Fusidic Acid by Cunninghamella echinulata
  50. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
  51. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
  52. Bioanalytical method development and validation of corynantheidine, a kratom alkaloid, using UPLC-MS/MS, and its application to preclinical pharmacokinetic studies
  53. Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids
  54. Total Phenolic and Flavonoid Content and Biological Activities of Extracts and Isolated Compounds of Cytisus villosus Pourr.
  55. Perspective on the Therapeutics of Anti-Snake Venom
  56. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats
  57. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra‐performance liquid chromatography−tandem mass spectrometry
  58. Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia
  59. Computationally aided stereochemical assignment of undescribed bisabolenes from Calea urticifolia
  60. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)
  61. Centaurea microcarpa Coss. & Dur. (Asteraceae) extracts: New cyanogenic glucoside and other constituents
  62. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats
  63. Humulene derivatives from Saharian Asteriscus graveolens
  64. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine
  65. Secondary metabolites from two Hispaniola Ageratina species and their cytotoxic activity
  66. 3′-Hydroxy-3,4′-dimethoxyflavone-induced cell death in human leukaemia cells is dependent on caspases and reactive oxygen species and attenuated by the inhibition of JNK/SAPK
  67. Isolation, Antioxidant and Antimicrobial Activities of Ecdysteroids from Serratula cichoracea
  68. Secondary metabolites from the aerial parts of Cytisus villosus Pourr.
  69. Evaluation of triazole and isoxazole derivatives as potential anti-infective agents
  70. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants
  71. 3′-Hydroxy-3,4′-dimethoxyflavone blocks tubulin polymerization and is a potent apoptotic inducer in human SK-MEL-1 melanoma cells
  72. Molecular Modeling Evaluation of the Enantiomers of a Novel Adenylyl Cyclase 2 Inhibitor
  73. Interactions of Desmethoxyyangonin, a Secondary Metabolite fromRenealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B
  74. Isolation of Acacetin from Calea urticifolia with Inhibitory Properties against Human Monoamine Oxidase-A and -B
  75. Components and antioxidant, anti-inflammatory, anti-ulcer and antinociceptive activities of the endemic species Stachys mialhesi de Noé
  76. Sesquiterpenoids Isolated from Two Species of the Asteriscus Alliance
  77. Secondary Metabolites, Evaluation of the DPPH Free-Radical Scavenging Effect by Electron Spin Resonance and Antibacterial Activity of the Endemic Species Stachys circinata
  78. Secondary Metabolites and Antioxidant Activity of Limonium duriusculum (de Girard) Kuntze Extracts
  79. In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera flower
  80. Secondary Metabolites from Linaria tingitana
  81. In vitro opioid receptor displacement affinity and in vitro behavioral studies by tetrad assay of Nelumbo nucifera flower
  82. Isolation of acacetin from Calea urticifolia as a potent inhibitor of human monoamine oxidase-A and B
  83. Isolation, chemical profiling, and standardization of betaine, choline, acetylcholine, and 20-hydroxyecdysone from Atriplex species
  84. Secondary metabolites isolated from Salvia bogotensis
  85. Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid Receptors
  86. Antinociceptive activity of extracts and secondary metabolites from wild growing and micropropagated plants of Renealmia alpinia
  87. Phytochemistry of Mitragyna speciosa
  88. Cannabinoid and opioid radioligand displacement by secondary metabolites from Banisteriopsis caapi
  89. Investigation of Nelumbo nucifera flower for human opioid receptor displacement affinity
  90. Phenolic compounds, antioxidant activity and ultrastructural study from Protea hybrid ‘Susara’
  91. Flavanones from Miconia prasina
  92. Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors
  93. Fatty Acids with in Vitro Binding Affinity for Human Opioid Receptors from the Fungus Emericella nidulans
  94. Correction to Neocosmospora sp.-Derived Resorcylic Acid Lactones with in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors
  95. A chemotaxonomic study of endemic species of genus Tanacetum from the Canary Islands
  96. New strategy toward the diverted synthesis of oxidized abietane diterpenes via oxidation of 6,7-dehydroferruginol methyl ether with dimethyldioxirane
  97. Neocosmospora sp.-Derived Resorcylic Acid Lactones with in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors
  98. A New Flavonoid C-Glycoside from Solanum elaeagnifolium with Hepatoprotective and Curative Activities against Paracetamol- Induced Liver Injury in Mice
  99. A New Flavonoid C-Glycoside from Solanum elaeagnifolium with Hepatoprotective and Curative Activities against Paracetamol-Induced Liver Injury in Mice
  100. Ayanin diacetate-induced cell death is amplified by TRAIL in human leukemia cells
  101. Secondary Metabolites from Two Species of Tolpis and Their Biological Activities
  102. Cell death triggered by synthetic flavonoids in human leukemia cells is amplified by the inhibition of extracellular signal-regulated kinase signaling
  103. Cytotoxic sesquiterpene lactones and other constituents of Centaurea omphalotricha
  104. A new flavonoid and other constituents fromCentaurea nicaeensisAll. var.wallianaM.
  105. Phytochemical study of Halimium halimifolium
  106. Antifungal Metabolites from the Roots of Diospyros virginiana by Overpressure Layer Chromatography
  107. Antimicrobial and antiprotozoal activities of secondary metabolites from the fungus Eurotium repens
  108. Secondary Metabolites from Two Species of Pulicaria and Their Cytotoxic Activity
  109. Benzyl Derivatives within VitroBinding Affinity for Human Opioid and Cannabinoid Receptors from the FungusEurotium repens
  110. Flavonoid aglycones and sterol from Chrysanthemum fontanesii
  111. Flavonoid aglycones from Centaurea maroccana
  112. Chemotaxonomy of Gonospermum and related genera
  113. Four flavonoids from the aerial part of Ononis angustissima species
  114. A flavonoid with cytotoxic activity and other constituents from Centaurea africana
  115. Sesquiterpene Lactones fromGonospermum gomeraeandG. fruticosumand Their Cytotoxic Activities
  116. Mycophenolic Derivatives fromEupenicilliumparvum
  117. Induction of G2-M phase arrest and apoptosis by α-methylene-γ-butyrolactones in human leukemia cells
  118. A new guaianolide and other constituents from Achillea ligustica
  119. Synthesis of novel spirostanic saponins and their cytotoxic activity
  120. The Presence of Capsule in Cryptococcus neoformans Influences the Gene Expression Profile in Dendritic Cells during Interaction with the Fungus
  121. A New Ceramide fromSuillus luteus and Its Cytotoxic Activity against Human Melanoma Cells
  122. Sesquiterpene lactones and other constituents from Matricaria chamomilla L.
  123. Revisiting the Reaction Between Diaminomaleonitrile and Aromatic Aldehydes: a Green Chemistry Approach
  124. Synthesis and antiproliferative activity of novel sugiol β-amino alcohol analogs
  125. Isolation, Structure Elucidation, Total Synthesis, and Evaluation of New Natural and Synthetic Ceramides on Human SK-MEL-1 Melanoma Cells
  126. A Homo-Isoflavonoid and a Cytotoxic Saponin fromDracaena draco
  127. A new guaianolide and other sesquiterpene lactones from Centaurea acaulis L. (Asteraceae)
  128. Sesquiterpenoids fromPulicariacanariensisand Their Cytotoxic Activities#
  129. Cladocalol, a pentacyclic 28-nor-triterpene from Eucalyptus cladocalyx with cytotoxic activity
  130. Lanostanoid Triterpenes fromLaetiporussulphureusand Apoptosis Induction on HL-60 Human Myeloid Leukemia Cells
  131. Icogenin, a new cytotoxic steroidal saponin isolated from Dracaena draco
  132. Isolation fromEucalyptusoccidentalisand Identification of a New Kaempferol Derivative that Induces Apoptosis in Human Myeloid Leukemia Cells
  133. Flavans of dragon’s blood from Dracaena draco and Dracaena tamaranae
  134. Novel Cytostatic Lanostanoid Triterpenes fromGanoderma australe
  135. Sesquiterpenoid Derivatives fromGonospermumelegansand Their Cytotoxic Activity for HL-60 Human Promyelocytic Cells#
  136. Synthesis and Antiproliferative Activity of a New Compound Containing an α-Methylene-γ-Lactone Group
  137. New Lanostanoids from the FungusGanodermaconcinna
  138. A facile chemoselective deacetylation in the presence of benzoyl and p-bromobenzoyl groups using p-toluenesulfonic acid
  139. Phenolic Compounds of Dragon's Blood fromDracaenadraco
  140. Synthesis of 2t-Substituted-1r,3c-BIS(2′-Hydroxy-5-Substituted-Benzyl)-Imidazolidines by Reaction of 1,3-BIS(2′-Hydroxy-5′-Substituted-Benzyl)-Imidazolidines with Aromatic Aldehydes
  141. Lanostanoid Triterpenes fromGanodermalucidum